Search

Annette M Shadiack

from Somerset, NJ
Age ~60
Get Report
Also known as:
Annette Marie Shadiack, Annettem Shadiack, Annett Shadiack, Shadiack Annett
Phone and address:
36 Buttonwood Dr, East Millstone, NJ 08873
(732) 220-1152
Related to:
Christine B Shadiack, 70Harriet Shadiack, 99Emily Rene ShadiackMichelle L Shadiack, 58Antoinette M Shadiack, 86M Shadiack, 58Joseph ShadiackThomas J Shadiack, 90
Connected to:
Mona Shadia, 41Rick A Shadick, 59Debra S Shadid, 60Janet A Shadid, 63Kal P Shadid, 63Khalid A Shadid, 60Michelle L Shadid, 44George A Shadie, 107Karen U Shadie, 59Andrea Shadik, 57

Annette Shadiack Phones & Addresses

  • 36 Buttonwood Dr, Somerset, NJ 08873 (732) 220-1152 (732) 568-1479
  • 11 Leahy Ct, Franklin Township, NJ 08873 (732) 568-1478
  • 2603 Jesse Way, Piscataway, NJ 08854 (732) 339-0405
  • Cleveland Heights, OH
  • Lansdale, PA
  • Paterson, NJ
  • Milltown, NJ

Work

Company: Elusys therapeutics, inc. Mar 2011 Position: Senior director, nonclinical development

Education

Degree: PhD School / High School: Rutgers, The State University of New Jersey-Newark 1986 to 1992 Specialities: Neuroscience

Skills

Drug Discovery • Drug Development • Biotechnology • Pharmaceutical Industry • Pharmacology • R&D • Assay Development • Biopharmaceuticals • Fda • Infectious Diseases • In Vitro • Toxicology • Cro • Regulatory Submissions • Immunology • Clinical Research • Glp • Animal Models • Cell • Team Leadership • Good Laboratory Practice • Research and Development • Monoclonal Antibodies • In Vivo • U.s. Food and Drug Administration • Laboratory • Neuroscience • Small Molecules • Peptides • Cell Biology • Cro Management • Nonclinical Development • Preclinical Safety • Small Biopharmaceutical • Project Management

Industries

Pharmaceuticals

Resumes

Resumes

Annette Shadiack Photo 1

Senior Biological Subject Matter Expert

View page
Location:
6800 Broken Sound Pkwy northwest, Boca Raton, FL 33487
Industry:
Pharmaceuticals
Work:
Elusys Therapeutics, Inc. since Mar 2011
Senior Director, Nonclinical Development
Global Alliance for TB Drug Development Mar 2009 - Mar 2011
Director, Preclinical Development
Locus Pharmaceuticals Oct 2007 - Dec 2008
Senior Director, Preclinical Development
Palatin Technologies Apr 1998 - Sep 2007
Exec Dir Preclinical R&D
Johnson and Johnson Sep 1996 - Apr 1998
Post-doctoral Scientist
Education:
Rutgers, The State University of New Jersey-Newark 1986 - 1992
PhD, Neuroscience Rutgers, The State University of New Jersey-Newark 1982 - 1986
BA, Zoology
Skills:
Drug Discovery
Drug Development
Biotechnology
Pharmaceutical Industry
Pharmacology
R&D
Assay Development
Biopharmaceuticals
Fda
Infectious Diseases
In Vitro
Toxicology
Cro
Regulatory Submissions
Immunology
Clinical Research
Glp
Animal Models
Cell
Team Leadership
Good Laboratory Practice
Research and Development
Monoclonal Antibodies
In Vivo
U.s. Food and Drug Administration
Laboratory
Neuroscience
Small Molecules
Peptides
Cell Biology
Cro Management
Nonclinical Development
Preclinical Safety
Small Biopharmaceutical
Project Management

Business Records

Name / Title
Company / Classification
Phones & Addresses
Annette Shadiack
Director Biological Research
Palatin Technologies, Inc
Mfg of Pharmaceutical Preparations · Pharmaceutical Preparations · Surgical & Medical Instrument Mfg
4 Cedarbrook Dr, East Windsor, NJ 08512
4B Cedarbrook Dr, East Windsor, NJ 08512
4C Cedarbrook Dr, Cranbury, NJ 08512
(609) 495-2200, (609) 495-2201

Publications

Us Patents

Cyclic Peptides For Treatment For Cachexia

View page
US Patent:
7342089, Mar 11, 2008
Filed:
Jul 5, 2005
Appl. No.:
11/174845
Inventors:
Shubh D. Sharma - Cranbury NJ, US
Ramesh Rajpurohit - Hillsboro NJ, US
Annette M. Shadiack - Somerset NJ, US
Yi-Qun Shi - East Brunswick NJ, US
Kevin D. Burris - Washington Crossing PA, US
Assignee:
Palatin Technologies, Inc. - Cranbury NJ
International Classification:
A61K 38/00
A61K 38/12
C07K 7/00
US Classification:
530312, 530317, 530321, 530300, 530328, 530329, 514 9, 514 11, 514 12, 514 15, 514 16, 514 18, 424 91, 436811
Abstract:
A highly selective melanocortin-4 receptor antagonist cyclic peptide of the formula.

Cyclic Peptides For Treatment Of Cachexia

View page
US Patent:
7345144, Mar 18, 2008
Filed:
Jul 5, 2005
Appl. No.:
11/174851
Inventors:
Shubh D. Sharma - Cranbury NJ, US
Ramesh Rajpurohit - Hillsboro NJ, US
Annette M. Shadiack - Somerset NJ, US
Yi-Qun Shi - East Brunswick NJ, US
Kevin D. Burris - Washington Crossing PA, US
Assignee:
Palatin Technologies, Inc. - Cranbury NJ
International Classification:
A61K 38/00
A61K 38/12
C07K 7/00
US Classification:
530312, 530317, 530321, 530300, 530328, 530329, 514 9, 514 11, 514 12, 514 15, 514 16, 514 18, 424 91, 436811
Abstract:
A highly selective melanocortin-4 receptor antagonist cyclic hexapeptide of the formula.

Linear And Cyclic Melanocortin Receptor-Specific Peptides

View page
US Patent:
7417027, Aug 26, 2008
Filed:
Jan 12, 2004
Appl. No.:
10/756212
Inventors:
Shubh D. Sharma - Cranbury NJ, US
Annette M. Shadiack - Somerset NJ, US
Wei Yang - Edison NJ, US
Ramesh Rajpurohit - Hillsboro NJ, US
Assignee:
Palatin Technologies, Inc. - Cranbury NJ
International Classification:
A61K 38/08
A61K 38/07
US Classification:
514 17, 514 18, 530329, 530330, 530331
Abstract:
Linear and cyclic peptides are provided specific to one or melanocortin receptors, and which exhibit agonist, antagonist, or mixed agonist-antagonist activity. In one embodiment, a linear peptide of the following general formula is provided:.

Melanocortin Receptor-Specific Compounds

View page
US Patent:
7456184, Nov 25, 2008
Filed:
Apr 30, 2004
Appl. No.:
10/837519
Inventors:
Shubh D. Sharma - Cranbury NJ, US
Yi-Qun Shi - East Brunswick NJ, US
Zhijun Wu - Plainsboro NJ, US
Ramesh Rajpurohit - Hillsboro NJ, US
Annette M. Shadiack - Somerset NJ, US
Papireddy Purma - Plainsboro NJ, US
Kevin D. Burris - Washington Crossing PA, US
Assignee:
Palatin Technologies Inc. - Cranbury NJ
International Classification:
A61K 31/497
C07D 403/02
US Classification:
51425409, 544373
Abstract:
A melanocortin receptor-specific compound of the general formula of structure I:.

Naphthalene-Containing Melanocortin Receptor-Specific Small Molecule

View page
US Patent:
7732451, Jun 8, 2010
Filed:
Jan 14, 2005
Appl. No.:
11/036282
Inventors:
Shubh D. Sharma - Cranbury NJ, US
Annette M. Shadiack - Somerset NJ, US
Yiqun Shi - East Brunswick NJ, US
Zhijun Wu - Plainsboro NJ, US
Ramesh Rajpurohit - Hillsboro NJ, US
Kevin D. Burris - Washington Crossing PA, US
Papireddy Purma - Plainsboro NJ, US
Assignee:
Palatin Technologies, Inc. - Cranbury NJ
International Classification:
A61K 31/4965
C07D 295/023
US Classification:
51425501, 544386
Abstract:
A method of modulating energy homeostasis in a mammal without eliciting a sexual response by administration of a therapeutically effective amount of a pharmaceutical composition including a melanocortin receptor compound of the formula:.

Melanocortin Receptor-Specific Compounds

View page
US Patent:
7964601, Jun 21, 2011
Filed:
Jun 2, 2008
Appl. No.:
12/131822
Inventors:
Shubh D. Sharma - Cranbury NJ, US
Yi-Qun Shi - East Brunswick NJ, US
Ramesh Rajpurohit - Hillsboro NJ, US
Zhijun Wu - Plainsboro NJ, US
Papireddy Purma - Plainsboro NJ, US
Annette M. Shadiack - Somerset NJ, US
Kevin D. Burris - Washington Crossing PA, US
Assignee:
Palatin Technologies, Inc. - Cranbury NJ
International Classification:
A61K 31/497
C07D 403/06
C07D 241/04
C07D 241/06
US Classification:
51425212, 51425213, 51425409, 544358, 544372, 544373
Abstract:
A melanocortin receptor-specific compound of the general formula of structure I:.

N-Alkylated Cyclic Peptide Melanocortin Agonists

View page
US Patent:
8247530, Aug 21, 2012
Filed:
Nov 7, 2006
Appl. No.:
11/557408
Inventors:
Shubh D. Sharma - Cranbury NJ, US
Yi-Qun Shi - East Brunswick NJ, US
Kevin D. Burris - Washington Crossing PA, US
Annette Shadiack - Somerset NJ, US
Ramesh Rajpurohit - Hillsboro NJ, US
Assignee:
Palatin Technologies, Inc. - Cranbury NJ
International Classification:
A61K 38/16
A61K 38/00
US Classification:
530312, 514 107, 514 218
Abstract:
A melanocortin-4 receptor agonist cyclic peptide of the formula.

Steroid Hormone Pharmaceutical Formulations

View page
US Patent:
20210244747, Aug 12, 2021
Filed:
Feb 5, 2021
Appl. No.:
17/169103
Inventors:
- Boca Raton FL, US
Annette Shadiack - Somerset NJ, US
Thorsteinn THORSTEINSSON - Boynton Beach FL, US
Peter H.R. PERSICANER - Boca Raton FL, US
International Classification:
A61K 31/565
A61K 9/00
A61K 9/48
Abstract:
This disclosure provides pharmaceutical compositions for delivering estradiol to a subject in need thereof, as well as methods of administering the compositions, and methods of using them.
Control profile
Annette M Shadiack from Somerset, NJ, age ~60 Get Report